Hepatitis B triple vaccine and developmental disability in US children 1-9

[Guest guest]

It's interesting that the title of the abstract mentions children but

the text says the study was done on boys (1-9):

http://www.informaworld.com/smpp/content~content=a905442343~db=all~jum

ptype=rss

Hepatitis B triple series vaccine and developmental disability in US

children aged 1-9 years

Authors: Carolyn Gallagher a; Melody Goodman a

Affiliation:

a Graduate Program in Public Health, Stony Brook University Medical

Center, Health Sciences Center, New York, USA

DOI: 10.1080/02772240701806501

Publication Frequency: 8 issues per year

Published in: Toxicological & Environmental Chemistry, Volume 90,

Issue 5 September 2008 , pages 997 - 1008

Subjects: Chemistry; Environmental & Ecological Toxicology;

Environmental Health; Environmental Sciences; Pollution;

Formats available: HTML (English) : PDF (English)

Previously published as: Toxicological & Environmental Chemistry

Reviews (0092-9867) until 1980

Abstract

This study investigated the association between vaccination with the

Hepatitis B triple series vaccine prior to 2000 and developmental

disability in children aged 1-9 years (n = 1824), proxied by parental

report that their child receives early intervention or special

education services (EIS). National Health and Nutrition Examination

Survey 1999-2000 data were analyzed and adjusted for survey design by

Linearization using SAS version 9.1 software, with SAS

callable SUDAAN version 9.0.1. The odds of receiving EIS were

approximately nine times as great for vaccinated boys (n = 46) as for

unvaccinated boys (n = 7), after adjustment for confounders. This

study found statistically significant evidence to suggest that boys

in United States who were vaccinated with the triple series Hepatitis

B vaccine, during the time period in which vaccines were manufactured

with thimerosal, were more susceptible to developmental disability

than were unvaccinated boys.

Keywords: early intervention; special education services;

developmental disability; Hepatitis B vaccine triple series